SAGE THERAPEUTICS INC's ticker is and the CUSIP is 78667J908. A total of 6 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $898,000 | +36.7% | 120 | +57.9% | 0.03% | +41.7% |
Q4 2020 | $657,000 | +119.7% | 76 | +55.1% | 0.02% | +33.3% |
Q3 2020 | $299,000 | -52.7% | 49 | -67.8% | 0.02% | -58.1% |
Q2 2020 | $632,000 | +64.2% | 152 | +13.4% | 0.04% | +34.4% |
Q1 2020 | $385,000 | -85.7% | 134 | -30.2% | 0.03% | -87.0% |
Q3 2019 | $2,694,000 | +678.6% | 192 | +814.3% | 0.25% | +384.3% |
Q4 2017 | $346,000 | -77.7% | 21 | -91.6% | 0.05% | -80.2% |
Q3 2017 | $1,551,000 | – | 249 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 1,000 | $3,013,000 | 0.78% |
SABBY MANAGEMENT, LLC | 4,009 | $12,079,000 | 0.63% |
Iguana Healthcare Management, LLC | 50,000 | $1,507,000 | 0.61% |
SIMPLEX TRADING, LLC | 38 | $8,000 | 0.00% |
GROUP ONE TRADING, L.P. | 100 | $3,000 | 0.00% |
Citadel Advisors | 11,500 | $346,000 | 0.00% |